Understanding longer term outcomes in critically ill patients will assist treatment decisions, allocation of scarce resources and clinical research in that population. The aim of this study was to compare a wellvalidated means of determining comorbidity, the Charlson Comorbidity Score, to other verified risk stratification models in predicting one-year mortality and other outcomes in emergency department patients with severe sepsis and sepsis with shock. We conducted a planned subgroup analysis of a prospective observational study, the Critical Illness and Shock Study, in adult patients with sepsis meeting study criteria for critical illness. From emergency department arrival, patients were prospectively enrolled with data collected for a minimum of one year post-enrolment. Scoring systems were derived from this data and compared using receiver-operating characteristic curves. One hundred and four patients were enrolled. The 28-day mortality was 18% and one-year mortality 40%. For predicting one-year mortality, the area under the receiver-operating characteristic curve for age-weighted Charlson Comorbidity Score (0.71, 95% confidence interval 0.61 to 0.81) was at least as good or superior to other scoring systems analysed. The intensive care unit admission rate was 45% and the median hospital length-of-stay was eight days. We conclude that in patients who present to the emergency department with severe sepsis or sepsis with shock, age-weighted Charlson Comorbidity Score is a predictor of one-year mortality that is simple to calculate and at least as accurate as other validated scoring systems.
The annual incidence of severe sepsis has been estimated at three per 1000 population, increasing sharply with age 1 . Over 80% of patients with severe sepsis are aged ≥65 years at the time of presentation 2 . Of patients with severe sepsis admitted to Australian and New Zealand intensive care units (ICU), substantial proportions die in the ICU (26%) within 28 days of diagnosis (32%) and during that hospital admission (37%) 3 . While understanding short-term mortality of severe sepsis and the many factors that influence it is imperative, longer term sequelae (both mortality and morbidity) are substantial and should also be understood when resuscitation decisions are commenced. The oneyear mortality in survivors of sepsis can approach 50% 4 and functional decline and requirement for institutional care after hospitalisation for severe sepsis is common 5 .
Not all critically ill patients with sepsis in the Emergency Department (ED) are admitted to the ICU, often because it is clinically unnecessary but also because the rationing of scarce critical care beds is frequently required 6 . Good information about likely patient outcomes can potentially be used in triage, resource allocation and treatment decisions for critically ill ED patients. Several scoring systems have been developed for use as prognostic tools though none are considered robust enough to dictate practice for individual patients. These include the Sequential Organ Failure Assessment (SOFA) score 7 used in the ICU setting, and the Mortality in Emergency Department Sepsis (MEDS) score which has been validated for patients with suspected infection in the ED 8 . These scores rely heavily on both physiological variables and laboratory tests. Particularly in relation to longer term sequelae, however, outcome from severe sepsis could be more influenced by the burden of chronic disease than these acute physiological changes captured by current prognostication tools.
The Charlson Comorbidity Score (CCS) is a welldescribed tool for quantification of comorbidity burden shown to correlate with mortality in a wide variety of settings, including ED patients with sepsis and suspected infection 9 and patients admitted to the ICU 10 . CCS also predicts higher healthcare costs in the first year after hospital discharge in survivors of severe sepsis 11 . We aimed to determine: 1. whether comorbidity burden, as measured by the CCS or age-weighted CCS (aWCCS), would be a better predictor of one year mortality in critically ill ED patients with severe sepsis than SOFA and MEDS; 2. the incremental benefit of combining these scores over use of single scores alone; and 3. the reliability of initial CCS determined from information obtained by ED staff at the time of presentation.
MATERIAlS AND METHODS

Study design
We planned subgroup analysis of a larger prospective observational study-the Critical Illness and Shock Study (CISS), using a cross-sectional comparison of different scoring systems. The CISS protocol is described elsewhere 12 . briefly, we collected clinical and biochemical data from critically ill ED patients in the initial hours of their presentation to hospital between 28 February 2010 and 28 February 2011, with patients followed up for a minimum of 12 months. The study is designed to test various hypotheses related to the pathophysiology and outcomes in critically ill patients. This study was approved by the RPH Human Research ethics Committee (eC 2009/080).
Study setting
Royal Perth Hospital is a major tertiary referral centre for adults in Western Australia. It has more than 65,000 ed presentations per year and a 45% admission rate.
Inclusion and exclusion criteria
Patients were eligible for enrolment in CISS if they met criteria as outlined in Table 1 . For this study, we used the subgroup of CISS patients that presented with severe sepsis or sepsis with shock.
Recruitment
Clinical staff in the ed identified eligible patients, with the assistance of Centre for Clinical Research in Emergency Medicine research nurses. Enrolled patients were a convenience sample, with enrolment occurring seven days a week and never outside of the hours of research nurse rostering (7 am to 9 pm). We have previously shown that CISS enrols only 15% of all critically ill patients arriving to the ED because of exclusion criteria or unavailability of research staff; therefore the sample in this study represents a relatively small and defined subset of severe sepsis cases from the study period 12 . Using procedures approved by the Royal Perth Hospital Ethics Committee, patients were initially enrolled under a waiver of consent. If the patient died or was rendered permanently incapacitated, ongoing enrolment in the study continued under the waiver. If the patient recovered, he or she had the opportunity to provide informed consent to continue in or withdraw from the study.
Data handling and risk score calculation
Comprehensive demographic, clinical, laboratory, therapeutic and outcome data were collected for all enrolled patients by research staff. The CCS ( Table  2 ) was determined using information available to ED staff at the time of patient assessment. The AWCCS was calculated by adding a score of 1 to the CCS for each decade of age above 40 13 . The Charlson Index was derived from grouping CCS into four categories: 0 points (none), 1 to 2 points (low), 3 to 4 points (moderate), and ≥5 points (high) 13 . The abbreviated MEDS 14 and the SOFa score (substituting SaO 2 :FiO 2 ratio where no arterial blood gas was available) 15 were calculated from CISS data using the worst parameters recorded during the ED stay (Tables 3 and 4 ).
To further explore the impact of comorbidity on outcome, we derived a number of composite scores through the sum or product of CCS and AWCCS with MEDS and SOFA.
Follow-up at one year was by review of the Open Patient Administration System, an administration system containing information from public hospitals in Western Australia, augmented by telephone follow-up.
We reviewed all patient medical records to assess whether the research nurse's estimate of each CCS in the ED was accurate. We did not assign a specific comorbidity if that condition was diagnosed during the CISS hospitalisation. as a final check, for every patient we obtained International Classification of diseases-10 codes for all admissions in the five years prior to our study to compare it to that calculated by research staff 16 . For each patient the verified CCS was therefore determined from the medical record and International Classification of diseases-10 codes, and compared to the original CCS recorded on enrolment.
Endpoints
The primary endpoint was one-year mortality. The secondary endpoints were 28-day mortality, hospital length-of-stay and ICU admission.
Power calculation
We did not undertake an a priori sample size calculation but did conduct a power calculation to determine the minimum difference our 12-month sample size would be able to detect between CCS and the most commonly quoted scoring system, MEDS. Assuming an area under the receiver operating characteristic (ROC) curve of 0.8 for MEDS, our sample size would be large enough to detect an area under the curve (AUC) difference of 0.12 with 1-β=0.8 and α=0.05.
Analysis
Summary statistics were analysed using median with interquartile range (IQR) for continuous variables and simple proportions for discrete variables. We used pearson's chi-square test to cross-tabulate the Charlson Index versus one-year mortality. The strength of the association between CCS/aWCCS and mortality was further evaluated using ROC curves. The AUC was used to compare the discriminatory power of CCS/aWCCS to the MEDS, SOFA and composite scores for mortality. We used a binary logistic regression model to further explore composite scores. A weighted kappa statistic was used to compare the original and verified CCS. all analysis was done using SpSS v.19 (IBM, Ny, USA).
RESUlTS
Table 5 summarises the study cohort. We recruited 104 patients of whom 92 had sepsis with shock and 12 had severe sepsis. The median age was 66 (IQr 52 to 79) years and 65 (64%) were male. all patients were admitted to hospital with a lengthof-stay ranging from one to 91 days (median eight days, IQr 4 to 15) and 47 (45%) were admitted to the ICU with a median ICU stay of two days (IQR 1 to 7).
When comparing the CCS originally recorded by research nurses to the verified score, weighted kappa for original against verified CCS = 0.78 (95% confidence interval [CI] 0.70 to 0.86), indicating very good correlation between calculated and verified CCS. median CCS was two (IQr 1 to 4) and median MEDS and SOFA scores were 11 (IQR 8 to 13) and six (IQr 4 to 9) respectively. mortality rates were 19 (18%) at 28 days, and 42 (40%) at one year. The Charlson index was not significantly associated with mortality at 28 days (P=0.55) but was significantly associated with mortality at one year, with mortality rates of 2/12 (17%), 12/34 (35%), 12/18 (67%) and 15/25 (60%) for patients with nil, low, moderate and high morbidity indices respectively (P=0.001). Of the 33 patients with a moderate or high Charlson index (i.e. CCS ≥3) who were alive at 28 days, more than half were dead at one year. Of the individual scores, SOFA was the best predictor of 28-day mortality (aUC 0.63) though with only 19 deaths and wide CIs, no scoring system was statistically better than chance for this secondary endpoint. Figure 1 shows the ROC curve for the primary study endpoint of one-year mortality for all subjects according to the individual scoring systems analysed: CCS, AWCCS, MEDS and SOFA. The curves indicate that on point estimates AWCCS is a better discriminator of mortality than either MEDS or SOFA with an AUC of 0.71, though the overlap of CIs indicates this difference between scores did not reach statistical significance (Table  6 ). Figure 2 represents the rOC for predicting ICU admission. This demonstrates that ICU admission is best discriminated by SOFA with an AUC of 0.74, a result that is statistically significant. all other systems performed no better than chance. However, AWCCS remains the best predictor of one-year mortality for the subset of patients admitted to the ICU (aUC 0.68) ( Table 7) . Table 8 contains the aUC and 95% CI for all derived composite scores versus one-year mortality. as can be seen, medS × aWCCS has the highest aUC but the result is not significantly different from that of aWCCS alone. This is confirmed in a binary logistic regression analysis including MEDS and AWCCS as explanatory variables, AWCCS (P <0.01) but not MEDS (P=0.22) was positively associated with one-year mortality.
DISCUSSION
We found that for predicting one-year mortality in critically ill septic patients presenting to the ed, the CCS/aWCCS perform as well as or better than SOFA, MEDS or composite derived scores, yet SOFA is the best determinant of ICU admission. There is no association between the decision to admit to the ICU and low or no comorbidity. Thus, it appears that while physiological status most strongly influences ICU admission, comorbidity burden is the primary determinant of outcome at one year. We also found that comorbidity burden can be accurately quantified in the ed setting.
Our study population had a 28-day mortality rate of 18% and one-year mortality rate of 40%.
The 28-day mortality in the medS derivation study was 5% with an aUC of 0.8 8 . This reflects the different study populations. MEDS is intended for use as a scoring system in all comers to the ED who have suspected infection, not necessarily those with critical sepsis-the medS study had 2.5% of patients with septic shock compared to 88% in our study. A study of MEDS restricted to patients with severe sepsis showed an in-hospital mortality rate of 23% and an aUC of 0.53 to 0.69 17 . Another study comparing MEDS in patients with an ED diagnosis of sepsis had a 28-day mortality rate of 23% 14 . MEDS has outperformed Acute Physiological and Chronic Health Evaluation (APACHE) II in risk stratification of ed patients with severe sepsis in prediction of 28-day mortality, with an aUC of 0.75 18 . Our 28-day mortality rate is thus similar to those found by other studies in comparable populations. MEDS has also been shown to predict one-year mortality in all comers with suspected infection in ED 19 . In a previous ed-based study, SOFa was calculated in patients with severe sepsis and septic shock to measure its predictive power for inhospital mortality. That population had a mortality rate of 21%, and the time-zero SOFa score performed well with an aUC of 0.75 20 . In our results, SOFA performed better than MEDS or aWCCS for predicting short-term mortality and ICU admission, but not long-term mortality, where AWCCS performed best.
We did not use a traditional ICU severity measure such as the APACHE III score in our study, even though this includes comorbidity weighting 21 . APACHE III is calculated based on the worst value measured for a number or variables after one full day of ICU care, which renders it impractical for use as a prognostic tool in the ED setting. For similar reasons, a delta SOFA score looking at a change in SOFA over days was not employed in our study. These scores may have provided better prognostic information in our population, but would have changed the emphasis of our study as we were interested in using information that can be obtained early in ED.
Determining CCS rests on the patient's history, using information that can be ascertained from the patient, their family and their medical record. CCS is thus a relatively easy tool to use and, though it can sometimes be difficult to obtain a full history in critically ill ED patients, we have shown that the agreement between the initial and verified CCS is excellent. However, the AUC of 0.71 is not robust enough to direct clinical decisions. To determine whether the observed 0.05 difference in aUC between MEDS and AWCCS was statistically significant would require a study sample of 700 subjects, and even then the clinical implications of detecting this difference where both scores are of only moderate discriminatory value is questionable.
Patients with severe sepsis and septic shock are critically unwell and often managed in an intensive care environment. An important feature of our study is that SOFA, and not CCS, predicted ICU admission. Therefore, the withholding of ICU care from patients with higher CCS, which might have influenced the results, was not a feature of our study.
We acknowledge several limitations to our study. Our estimates lack precision due to our small sample size. The study was conducted at a single centre in a select group of patients with only severe sepsis and septic shock, and as such our results should not be extrapolated to other patient populations. Many critically ill septic patients from the study period were not enrolled in CISS and available for analysis. To this effect, although the median age in our study was 66, other studies have found an even more skewed distribution of cases in the elderly. Inclusion criteria used in CISS may be selecting younger patients into CISS as they are more easily identified. although by their nature the scoring systems studied as comparisons to CCS are multivariate, it is possible other important confounders that influence outcome in our sample are not captured by any of these systems. Of those patients who did not go to the ICU in our study, we do not know how many of them were declined ICU admission versus not referred to the ICU. However as we found no association between CCS and ICU admission we have no reason to believe that patients with high comorbidity burden being declined ICU care influenced our primary outcome. Finally, because we were using hospital discharge data, we could only describe death, but not longer term post-discharge outcomes.
We have demonstrated that in a small population of patients who present to ED with severe sepsis or shock with sepsis, AWCCS is a reasonable discriminator of longer-term mortality. We found composite scores of AWCCS with MEDS or SOFA added little to the utility of AWCCS alone. Further information from CISS is required to determine whether the addition of other laboratory and clinical information could achieve different results. In addition to longer-term mortality prediction, it is important to be able to predict quality of life measures such as requirement for institutional care and disability, especially with an ageing population. The ability to predict outcome incorporating measures such as AWCCS will assist in the early risk stratification of patients with severe sepsis and shock. This is important not only for research in this population but ultimately clinical decisions regarding resuscitation and ICU resource allocation. It is also conceivable that understanding which patients are at very high risk of one-year mortality will enable improved end-of-life care in this group, allowing appropriate discussions to take place in survivors of an acute episode using an advance care planning framework.
CONClUSION
In patients who present to ED with severe sepsis or sepsis with shock, age-weighted CCS is a predictor of one year mortality that is simpler to calculate and at least as accurate as other validated scoring systems, but which has only moderate discriminatory value as a stand-alone measurement.
